Answer
After taking Korserdu (elacestrant dihydrochloride), elacestrant’s elimination half-life is predicted to be approximately 30 hours, with the geometric mean elimination half-life tending to increase with increasing severity of hepatic impairment.
Sources for this answer
- Korserdu (elacestrant) 345mg film-coated tabletsMenarini Stemline UK Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 4Document updated
Sources checked